Treatment of severe pulmonary hypertension secondary to scleroderma: A three-drug approach

10Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

We present a case of scleroderma complicated by severe pulmonary hypertension. The use of a three-drug (bosentan, iloprost, and sildenafil) approach contributed to significant improvement of both the clinical conditions and the pulmonary hemodynamics. Combining three pulmonary vasodilators with different mechanisms of action could benefit patients with severe pulmonary hypertension resistant to conventional therapy. © 2008 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Catapano-Minotti, G., Corsonello, A., Guadalupi, G., Spani, R., & Antonelli-Incalzi, R. (2008). Treatment of severe pulmonary hypertension secondary to scleroderma: A three-drug approach. Internal Medicine, 47(6), 511–513. https://doi.org/10.2169/internalmedicine.47.0565

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free